Clinical Trial Update: The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating the effects of a compound on skin reactions from glatiramer acetate injections was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ethyl-Alpha-Guanido-Methyl Ethanoate
• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: University of Nebraska | Conditions: Multiple Sclerosis | Phase 4 | Status: WITHDRAWN